Neuroprotection by silencing iNOS expression in a 6-OHDA model of Parkinson's disease (Q39341263)

11 September 2017

Neuroprotection by silencing iNOS expression in a 6-OHDA model of Parkinson's disease (English)

1 reference

11 September 2017

1 reference

Min Li

1

1 reference

11 September 2017

Fu-rong Dai

2

1 reference

11 September 2017

Xiao-ping Du

3

1 reference

11 September 2017

Qi-dong Yang

4

1 reference

11 September 2017

Yuxiang Chen

5

1 reference

11 September 2017

26 May 2012

1 reference

Journal of Molecular Neuroscience

11 September 2017

1 reference

11 September 2017

48

1 reference

11 September 2017

1

1 reference

11 September 2017

225-233

1 reference

https://scigraph.springernature.com/pub.10.1007/s12031-012-9814-5

11 September 2017

0 references

cites work

Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9814-5

Role of nitric oxide in a progressive neurodegeneration model of Parkinson's disease in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9814-5

Intranigral iron injection induces behavioral and biochemical "parkinsonism" in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9814-5

Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9814-5

The 6-hydroxydopamine model: news from the past

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9814-5

Chronic progesterone treatment of male rats with unilateral 6-hydroxydopamine lesion of the dorsal striatum exacerbates [corrected] parkinsonian symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9814-5

Rescue from death but not from functional impairment: caspase inhibition protects dopaminergic cells against 6-hydroxydopamine-induced apoptosis but not against the loss of their terminals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9814-5

Nitric oxide in the injured spinal cord: synthases cross-talk, oxidative stress and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9814-5

Parkinson's disease: mechanisms and models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9814-5

Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9814-5

Confirmation of the protective effect of iNOS in an independent cohort of Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9814-5

Oxidative stress and inflammation in Parkinson's disease: is there a causal link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9814-5

Neuronal NOS and cyclooxygenase-2 contribute to DNA damage in a mouse model of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9814-5

Oxidative stress-triggered unfolded protein response is upstream of intrinsic cell death evoked by parkinsonian mimetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9814-5

Parkinsonian mimetics induce aspects of unfolded protein response in death of dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9814-5

Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9814-5

Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9814-5

Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9814-5

Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9814-5

Loss of dopaminergic neurons by the induction of inducible nitric oxide synthase and cyclooxygenase-2 via CD 40: relevance to Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9814-5

Targeted expression of BCL-2 attenuates MPP+ but not 6-OHDA induced cell death in dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9814-5

Astroglial and microglial reaction after a partial nigrostriatal degeneration induced by the striatal injection of different doses of 6-hydroxydopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9814-5

Nitric oxide and reactive oxygen species in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9814-5

Selective upregulation of inducible nitric oxide synthase (iNOS) by lipopolysaccharide (LPS) and cytokines in microglia: in vitro and in vivo studies

21 January 2018

1 reference

12 December 2020

Nitric oxide synthase and neuronal vulnerability in Parkinson's disease.

1 reference

12 December 2020

Neuroprotection by the selective iNOS inhibitor GW274150 in a model of Parkinson disease

1 reference

12 December 2020

Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo

1 reference

12 December 2020

Caspase-dependent and -independent cell death pathways in primary cultures of mesencephalic dopaminergic neurons after neurotoxin treatment.

1 reference

12 December 2020

10.1007/S12031-012-9814-5

Identifiers

DOI

1 reference

11 September 2017

1 reference